Collegium Pharmaceutical, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 23.8 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 774.82M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company’s portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxyco...